ES336999A1 - Imidazo-(1,5-a)-quinoline Derivatives - Google Patents

Imidazo-(1,5-a)-quinoline Derivatives

Info

Publication number
ES336999A1
ES336999A1 ES336999A ES336999A ES336999A1 ES 336999 A1 ES336999 A1 ES 336999A1 ES 336999 A ES336999 A ES 336999A ES 336999 A ES336999 A ES 336999A ES 336999 A1 ES336999 A1 ES 336999A1
Authority
ES
Spain
Prior art keywords
lower alkyl
piperazinyl
pyrrolidinyl
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES336999A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES336999A1 publication Critical patent/ES336999A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Novel compounds of Formula I or a pharmaceutically acceptable acid addition salt thereof wherein R and R 1 are hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl R 2 is hydrogen, lower alkyl or halogen, Y is oxygen or sulphur n is an integer from 1 to 4 and R 3 and R 4 are hydrogen, lower alkyl, lower alkenyl, cycloalkyl, aralkyl, or lower (cycloalkyl) methyl, or -NR 3 R 4 , when taken together, is 1-pyrrolidinyl, lower alkyl-1-pyrrolidinyl, piperidino, lower alkylpiperidino, morpholino, lower alkylmorpholino, hexamethyleneimino, 1-piperazinyl, 1 -(lower alkyl) -4-piperazinyl, 1 -(hydroxy lower alkyl)-4-piperazinyl, 1 - (lower alkanoyloxyalkyl) - 4 - piperazinyl- 1 - phenyl - 4 - piperazinyl, 1 - (lower alkoxyphenyl) - 4 - piperazinyl, 1 - trifluoromethyl, phenyl - 4 - piperazinyl, 1 - (lower alkylphenyl)- 4 - piperazinyl, 1 - halophenyl - 4 - piperazinyl, 4 - phenyl - 1,2,4,5 - tetrahydro - 1 - pyridinyl, 4 - alkylphenyl - 1,2,5,6 - tetrahydro - 1- pyridinyl, 4 - halophenyl - 1,2,5,6 - tetrahydro- 1 - pyridinyl, 4 - lower alkoxyphenyl - 1,2,5,6- tetrahydro - 1 - pyridinyl, 4 - trifluoromethylphenyl - 1,2,5,6 - tetrahydro - 1 - pyridinyl or azabicyclo - [3.2.2] - nonan - 3 - yl or -C n H 2n - NR 3 R 4 , when taken together, is (2-pyrrolidinyl)- lower alkyl, (3-pyrrolidinyl) lower alkyl, (1- lower alkylpyrrolidinyl) lower alkyl, (1-benzylpyrrolidinyl) - lower alkyl, [1 - (halobenzyl)- pyrrolidinyl - lower alkyl, (1 - lower alkylpyrrolidinyl) - lower alkyl, (1 - benzylpyrrolidinyl) - lower alkyl, [1 - (halobenzyl) - pyrrolidinyl] - lower alkyl, [1 - (lower alkoxybenzyl)- pyrrolidinyl] - lower alkyl, [1 - (lower alkylbenzyl) - pyrrolidinyl] - lower alkyl, piperidinyl lower alkyl, (1-lower alkyl piperdinyl)- lower alkyl, (1 -benzylpiperidinyl)-lower alkyl, [1 - (halobenzyl) - piperidinyl] - lower alkyl, [1 - (lower alkoxybenzyl) - piperidinyl] - lower alkyl, or [1 - (lower alkylbenzyl) - piperidinyl]- lower alkyl and radicals qualified by the term " lower " contain up to 4 carbon atoms are prepared either (a) by heating a compound of Formula II wherein Z is H or -C n H 2n X wher X is halogen, (C 1 -C 4 ) alkylsulphonyloxy or arylsulphonyloxy, (1) when Z is H, with a compound of formula X-C n H 2n NR 3 R 4 or (2) when Z is C n H 2n X 1 with a compound of formula H-NR 3 - R 4 , in both eases optionally followed by reacting the product with P 2 S 5 and/or salt formation and/or removal of a group R 3 is benzyl by hydrogenolysis or (b) reacting a compound of formula with a cyclizing agent providing a carbonyl or thioketone group such as phosgene, thiophosgene, ethyl chloroformate or N,N1-carbonyl diimidazole or (c) where n is 1 by reaction of a compound of Formula II above with formaldehyde/formic acid and a compound of formula HNR 3 R 4 . 2 - (3 - Bromopropyl) - 3,3a,4,5 - tetrahydroimidazo - [1,5-a] - quinolin - 1 - (2H) - one is prepared by reaction of 1,3-dibromopropane and the 2-unsubstituted compound. Pharmaceutical compositions in conventional forms for oral administration and having tranquilizing activity comprise an above novel compound or salt and a carrier therefor.
ES336999A 1966-02-18 1967-02-18 Imidazo-(1,5-a)-quinoline Derivatives Expired ES336999A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52835466A 1966-02-18 1966-02-18

Publications (1)

Publication Number Publication Date
ES336999A1 true ES336999A1 (en) 1968-06-01

Family

ID=24105342

Family Applications (1)

Application Number Title Priority Date Filing Date
ES336999A Expired ES336999A1 (en) 1966-02-18 1967-02-18 Imidazo-(1,5-a)-quinoline Derivatives

Country Status (9)

Country Link
BE (1) BE694205A (en)
CH (1) CH521366A (en)
DE (1) DE1645955A1 (en)
ES (1) ES336999A1 (en)
FR (2) FR6101M (en)
GB (1) GB1172426A (en)
IL (1) IL27396A (en)
NL (1) NL6702347A (en)
SE (1) SE335345B (en)

Also Published As

Publication number Publication date
NL6702347A (en) 1967-08-21
DE1645955A1 (en) 1970-07-16
SE335345B (en) 1971-05-24
IL27396A (en) 1971-03-24
GB1172426A (en) 1969-11-26
BE694205A (en) 1967-08-17
FR6101M (en) 1968-06-10
FR1511914A (en) 1968-02-02
CH521366A (en) 1972-04-15

Similar Documents

Publication Publication Date Title
KR880011123A (en) N-benzhydryl-substituted heterocycle derivatives, preparation methods thereof
ES337526A1 (en) Polycyclic piperazines
KR920008031A (en) Quinazolin derivatives and preparation method thereof
KR880001656A (en) 1,2,3,3a, 8,8a-hexahydro-3a, 8 (and 1,3a, 8) -di (and tri) methylpyrrolo [2,3-b] indole and preparation method thereof
PT71940A (en) Process for preparing morpholine derivatives
ES2111654T3 (en) PIPERAZINE DERIVATIVES AS 5-HT1A ANTAGONISTS.
ATE74352T1 (en) DECAHYDROCHINOLINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE, INTERMEDIATE PRODUCTS FOR THEIR MANUFACTURE, THEIR USE AS MEDICINAL PRODUCTS AND PREPARATIONS CONTAINING THEM.
ATE53032T1 (en) 2-THIAZOLYLIMIDAZO(1,2-A)PYRIMIDINE AND THEIR SALTS, PROCESSES FOR THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS AND PREPARATIONS CONTAINING THEM.
ES470270A1 (en) 11-(Piperazino-acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones and salts thereof
DE3274860D1 (en) Triazoloquinazolones and their salts, process and intermediates for preparing them, their use as medicines and compositions containing them
ES336999A1 (en) Imidazo-(1,5-a)-quinoline Derivatives
HU896638D0 (en) Process for the preparation of acyloxypropanolamines and pharmaceutical compositions thereof
KR910020007A (en) 3- [1-thiazolidinylbutyl-4-piperazinyl] -1H-indazole, preparation method thereof and use thereof as a medicament
GB1033920A (en) Novel derivatives of triphenylethanols
GB1437023A (en) Substituted benzene-1,3-disulphonamides and process for their manufacture
FI871253A0 (en) 1- / 3- (2-DIALKYLAMINOETHOXY) -2-THENYL / -3-PHENYL-1-PROPANONER FOR THE SYRAADDITIONSSALTER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL SAMMANSAETTNINGAR.
GB995366A (en) Imidazolidine derivatives
KR900004730A (en) 4- [4- (3-benzisothiazolyl) -1-piperazinyl] butyl crosslinked bicyclic imide as an antipsychotic
GB1215132A (en) Physiologically active amine derivatives of thiophthalane
ES8308315A1 (en) Anilino-1,2,3-triazole derivatives, medicaments containing them, process for preparing them, and their use.
GB1031743A (en) Improvements in or relating to dibenzthiepin derivatives
GB1022045A (en) Substituted 4-thiazolidinones and preparation thereof
RU98117846A (en) METHOD FOR BINDING THIOLS
GB1084996A (en) Dibenzocyclohepten-5-yl-acetic acid esters
KR830001293A (en) New process for the production of products derived from 7-aminothiazolylacetoamido cephalosporanic acid